Currently out of the existing stock ratings of Morten Herholdt, 6 are a BUY (54.55%), 3 are a HOLD (27.27%), 2 are a SELL (18.18%).

Morten Herholdt

Work Performance Price Targets & Ratings Chart

Analyst Morten Herholdt, currently employed at HSBC, carries an average stock price target met ratio of 29.17% that have a potential upside of 6.64% achieved within 190 days.

Morten Herholdt’s has documented 21 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on GILD, Gilead Sciences at 06-Jul-2026.

Wall Street Analyst Morten Herholdt

Analyst best performing recommendations are on GILD (GILEAD SCIENCES).
The best stock recommendation documented was for GILD (GILEAD SCIENCES) at 9/6/2023. The price target of $71 was fulfilled within 8 days with a profit of $3.29 (4.86%) receiving and performance score of 6.07.

Average potential price target upside

BIIB Biogen GILD Gilead Sciences JNJ Johnson & Johnson ZTS Zoetis

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 21-Jul-2025

$235

$32.81 (16.23%)

$189

18 days ago
(13-Jul-2026)

5/8 (62.5%)

$25.97 (12.42%)

164

Hold Since 13-Feb-2025

$222

$19.81 (9.80%)

$224

23 days ago
(08-Jul-2026)

38/66 (57.58%)

$21.64 (10.80%)

321

Buy Since 04-Mar-2022

$242

$39.81 (19.69%)

$227

24 days ago
(07-Jul-2026)

48/83 (57.83%)

$36.3 (17.65%)

148

Buy Since 29-Jun-2026

$256

$53.81 (26.61%)

$255

1 months 2 days ago
(29-Jun-2026)

7/37 (18.92%)

$39.37 (18.17%)

256

Buy Since 28-Sep-2022

$221

$4.97 (2.30%)

$177

1 months 16 days ago
(15-Jun-2026)

24/40 (60%)

$22.36 (11.26%)

155

Show more analysts

Please expand the browser size to see the chart

Which stock is Morten Herholdt is most bullish on?

Potential upside of $25.69 has been obtained for GILD (GILEAD SCIENCES)

Which stock is Morten Herholdt is most reserved on?

Potential downside of $16.6 has been obtained for JNJ (JOHNSON & JOHNSON)

What Year was the first public recommendation made by Morten Herholdt?

On 2023

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?